美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

GSK plc ADRhedged

67.19

+0.89981.36%

成交量：3

成交额：199

市值：67.19万

市盈率：- -

高：67.19

开：66.29

低：67.19

收：66.29

52周最高：85.03

52周最低：61.00

股本：1.00万

流通股本：1.00万

量比：0.01

换手率：0.03%

股息：2.08

股息率：3.09%

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

中国银河证券：实验动物为创新药研发刚需小鼠+猴双主线高景气

葛兰素史克：董事会批准根据公司净资产，按资产市场价值分配公司合并后股本。

百花医药股价严重异常波动：主营小分子化学仿制药CRO业务不涉及创新药研发

百花医药(600721.SH)：不涉及创新药研发

百花医药(600721.SH)：不涉及创新药研发

东方证券：AI重构创新药研发底座国内相关产业链公司亦有望受益

数据简报-全球制药企业斥资数十亿以扩大在美国的市场份额

GLP-1为王、专利悬崖逼近、新赛道抢跑跨国药企2026上半年业绩背后的版图重组

每日经济新闻

GLP-1为王、专利悬崖逼近、新赛道抢跑：跨国药企2026上半年业绩背后的版图重组

每日经济新闻

阿斯利康拟与百时美施贵宝4000亿美元重组传闻背后：专利悬崖、产品短板倒逼，AZ端反对声大

据英国金融时报报道英国制药商阿斯利康一直在探索与美国竞争对手百时美施贵宝合并的交易合并后将打造全球最大的制药集团之一市值

GSK上半年核心营业利润增长管线优化同步推进

经济参考网

美股异动 | 医药板块走强葛兰素史克(GSK.US)绩后大涨超7%

美股异动｜医药股板块普涨，葛兰素史克涨近7%，安进涨超5%，艾伯维公司涨近4%，辉瑞、默沙东涨超3%

老虎资讯综合

美股开盘 | 三大指数涨跌不一，康宁跌超14%，葛兰素史克涨超4%，可口可乐涨超3%

老虎资讯综合

葛兰素史克首席执行官：媒体电话会议发言称，我们认为公司现有营收与收益流规模充足，足以抵消艾滋病药物专利失效带来的损失。

葛兰素史克首席执行官就剑桥投资表示，我们并未寻求英国政府支持。

葛兰素史克拟在英国剑桥生物医学园区建立新旗舰研发中心

葛兰素史克美股盘前涨超5%

葛兰素史克：未来三年内向英国投资4亿英镑

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/GSKH/news?page=2"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GSKH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","market":"US","secType":"STK","nameCN":"GSK plc ADRhedged","latestPrice":67.1856,"timestamp":1791835200000,"preClose":66.2858,"halted":0,"volume":3,"delay":0,"changeRate":0.013574551412217988,"floatShares":10001,"shares":10001,"eps":0,"marketStatus":"盘前交易","change":0.8998,"latestTime":"10-13 07:26:18 EDT","open":66.2858,"high":67.1856,"low":67.1856,"amount":199,"amplitude":0,"askPrice":106.82,"askSize":100,"bidPrice":27.01,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791898200000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":67.1856,"nav":66.281474,"aum":662881.021474,"dividendRate":0.030899,"bidAskSpread":0,"volumeRatio":0.010482182491023583,"impliedVol":0.3657,"impliedVolPercentile":0.9925},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GSKH\",,,,,undefined,":{"symbol":"GSKH","floatShares":10001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.010482182491023583,"shares":10001,"dividePrice":2.076,"high":67.1856,"amplitude":0,"preClose":66.2858,"low":67.1856,"week52Low":61,"pbRate":"--","week52High":85.03,"institutionHeld":0,"latestPrice":67.1856,"eps":0,"divideRate":0.030899,"volume":3,"delay":0,"ttmEps":0,"open":66.2858,"prevYearClose":68.2031,"prevWeekClose":66.2858,"prevMonthClose":68.5811,"prevQuarterClose":68.5811,"fiveDayClose":66.3846,"twentyDayClose":69.8025,"sixtyDayClose":71.9041},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GSKH\",params:#limit:5,,,undefined,":[{"date":"2026-06-16","symbol":"GSKH","amount":0.92785,"announcedDate":"2026-06-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-16","defaultRemindTime":1781616600000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-16","currency":"USD","dateTimestamp":1781582400000,"payDate":"2026-06-23"},{"date":"2026-03-16","symbol":"GSKH","amount":0.36332,"announcedDate":"2026-03-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-16","defaultRemindTime":1773667800000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-23","payableDate":"2026-03-16","currency":"USD","dateTimestamp":1773633600000,"payDate":"2026-03-23"},{"date":"2025-12-16","symbol":"GSKH","amount":0.78682,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"GSK plc ADRhedged","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GSKH\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-24","value":0.78682,"currency":"USD"},{"executeDate":"2026-03-16","recordDate":"2026-03-16","paymentDate":"2026-03-23","value":0.36332,"currency":"USD"},{"executeDate":"2026-06-16","recordDate":"2026-06-16","paymentDate":"2026-06-23","value":0.92785,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GSKH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GSKH\",pageSize:20,pageCount:2,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659504119","title":"中国银河证券：实验动物为创新药研发刚需 小鼠+猴双主线高景气","url":"https://stock-news.laohu8.com/highlight/detail?id=2659504119","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659504119?lang=zh_cn&edition=fundamental","pubTime":"2026-08-14 15:07","pubTimestamp":1786691225,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中国银河证券发布研报称，实验动物为创新药研发刚需，行业壁垒深厚，两大细分赛道具备中长期成长逻辑：人源化小鼠赛道成长确定性更强、周期波动平缓;实验猴赛道供给约束强，短期价格上行带来显著业绩弹性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479960.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["PBE","SBIO","BBP","BK0188","GDOC","XLVI","APXH","BK1564","WRND","BK0276","161027","IBB","BK4585","LFSC","601881","BK4588","06881","BIOY","BK1147","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659945158","title":"葛兰素史克：董事会批准根据公司净资产，按资产市场价值分配公司合并后股本。","url":"https://stock-news.laohu8.com/highlight/detail?id=2659945158","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659945158?lang=zh_cn&edition=fundamental","pubTime":"2026-08-13 17:58","pubTimestamp":1786615104,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GSK.UK","GSKH","BK4585","BK4532","BK4007","LU1829250122.USD","GSK","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903675","title":"百花医药股价严重异常波动：主营小分子化学仿制药CRO业务 不涉及创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903675","media":"央广财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658903675?lang=zh_cn&edition=fundamental","pubTime":"2026-08-12 21:27","pubTimestamp":1786541220,"startTime":"0","endTime":"0","summary":"8月12日，百花医药（维权）（600721.SH）发布公告称，公司股票连续10个交易日内日收盘价格涨幅偏离值累计超过100%，根据上交所的有关规定，属于股票交易严重异常波动情形。公司是以小分子化学仿制药研发为主的CRO企业，不涉及创新药研发。公司2026年第一季度实现营业收入6718.29万元，同比下降30.68%，归属于上市公司股东的净利润664.27万元，同比下降67.94%。目前公司主营业务未发生重大变化，市场环境、行业政策没有发生重大调整，股价短期内连续上涨，涨幅与公司经营情况严重偏离。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-12/doc-ininamih5206238.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PBE","600721","APXH","BK0216","BK4585","LFSC","XLVI","GSKH","BK4588","GDOC","BIOY","WRND","BK0102","IBB","SBIO","BBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658692990","title":"百花医药(600721.SH)：不涉及创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2658692990","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658692990?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 20:03","pubTimestamp":1786449780,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","IBB","BK4588","BIOY","GSKH","SBIO","PBE","BBP","GDOC","LFSC","WRND","XLVI","APXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658667990","title":"百花医药(600721.SH)：不涉及创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2658667990","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658667990?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 20:03","pubTimestamp":1786449780,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百花医药(600721.SH)发布股票交易风险提示公告称，公司是以小分子化学仿制药研发为主的CRO企业，主营业务是为客户提供小分子化仿药为主的药物研发注册“一站式”全流程服务，主要研发项目多来自于客户委托加部分的公司自主立项，不涉及创新药研发。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","BIOY","BK4585","BBP","GDOC","SBIO","WRND","GSKH","BK0102","APXH","BK4588","PBE","600721","XLVI","IBB","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658962968","title":"东方证券：AI重构创新药研发底座 国内相关产业链公司亦有望受益","url":"https://stock-news.laohu8.com/highlight/detail?id=2658962968","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658962968?lang=zh_cn&edition=fundamental","pubTime":"2026-08-11 14:06","pubTimestamp":1786428403,"startTime":"0","endTime":"0","summary":"东方证券主要观点如下：技术颠覆成本，AI重构制药“快与省”是中国创新药崛起的底层逻辑，根基是人才红利和成本优势。专家与AI协同，将真正提升新药研发的成功率并缩短周期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478422.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CHAT","GDOC","BIOY","BK4585","03958","BK1564","LFSC","GSKH","WRND","BK1147","ARTY","BK0188","SBIO","BK0276","XLVI","BK4588","BK0183","BK0012","AIPO","PBE","BBP","BK0028","600958","AGIX","IBB","VTHR","QTOC","APXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931998","title":"数据简报-全球制药企业斥资数十亿以扩大在美国的市场份额","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931998","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931998?lang=zh_cn&edition=fundamental","pubTime":"2026-08-10 21:18","pubTimestamp":1786367928,"startTime":"0","endTime":"0","summary":"数据简报-全球制药企业斥资数十亿以扩大在美国的市场份额修改发稿日期，补充百时美施贵宝的投资计划路透8月10日-全球制药企业正扩大在美国的业务布局，承诺投入数十亿美元以提升该国的生产能力和研发实力。该公司于6月表示，已在佛罗里达州杰克逊维尔投资约10亿美元，以加强其眼科护理业务在美国的制造能力。赛诺菲计划通过直接投资公司现有基地以及与其他国内制造商建立合作伙伴关系，扩大其在美国的生产能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4T4470YN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130102774.USD","LU2129689605.HKD","LU2106854487.HKD","CSL.AU","CANC","LU1883839398.USD","LU0208291251.USD","PAWZ","LU2360106947.USD","BMED","LU0211331839.USD","BK4007","LU0889566641.SGD","LU0006306889.USD","LU0320765059.SGD","LU0882574139.USD","IE00BFTCPJ56.SGD","LU1712237335.SGD","LU2461242641.AUD","BK7067","LU0323591593.USD","LU0133085943.USD","LU0820561818.USD","LU0889565916.HKD","LU0234570918.USD","SG9999015978.USD","IE000SO60NU8.SGD","LU2089284900.SGD","LU2168564222.USD","LU2491050071.SGD","LU2236285917.USD","LU0266013472.USD","LU0432979614.USD","LU0316494557.USD","LU0683600562.USD","LU0965509283.SGD","LU2357627491.SGD","LU0256863811.USD","FTXH","LU0345770308.USD","LU1059921491.USD","SG9999002224.SGD","LU1127390331.HKD","LU0029864427.USD","LU2271345857.HKD","LLII","LU0154236417.USD","LU0124676726.USD","LU0345769631.USD","LU1201861249.SGD","LU0823434583.USD","LU1074936037.SGD","GSKH","LU0106261372.USD","IE00BJJMRZ35.SGD","LLYX","LU2552382058.USD","LU1066051811.HKD","IE00BDGV0183.EUR","MHIP","IE00B4R5TH58.HKD","LU0256863902.USD","LU0795875169.SGD","LU0310800379.SGD","LU1496350171.SGD","LU2133065610.SGD","LLYZ","LU1116320901.HKD","GLAM","IE00BVYPNW00.USD","LU1066053197.SGD","LU0417517546.SGD","LU1244550494.USD","LU0820561909.HKD","LU0114720955.EUR","SG9999014914.USD","LU0477156953.USD","IE00B1BXHZ80.USD","LU2211815571.USD","IE00BLSP4452.SGD","LU2347655156.SGD","LU1720051017.SGD","LU1917777945.USD","BK4534","LU0203345920.USD","VHT","LU2237443465.HKD","LU1814569148.SGD","LU2129689431.USD","LU1979441026.SGD","IE0034235303.USD","NVO","LU0072461881.USD","LU0545039389.USD","LU2108987350.USD","LU0321505439.SGD","LU1988902786.USD","LU0868494617.USD","IE00B4JS1V06.HKD","BK4533","LU1868837136.USD","LU1670711040.USD","LU0868494708.USD","LU2125909593.SGD","LU0472753341.HKD","LU0882574055.USD","LU2491049909.HKD","LU2746668974.SGD","LU0823416689.USD","WDNA","LU0128525929.USD","BK4578","LU1670627923.USD","LU1228905540.USD","SG9999014542.SGD","LU2756315318.SGD","LU1267930730.SGD","BK7508","LU0353189763.USD","LU0792757196.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","HRTS","BMY","LU1974910355.USD","LU2592432038.USD","LU0320765992.SGD","ELIL","LU1914381329.SGD","LU0061475181.USD","LU0708995401.HKD","LU1496350502.SGD","LU1121112475.USD","IE00B19Z3B42.SGD","IE00BBT3K403.USD","SG9999002232.USD","LU2505996509.AUD","LU1551013342.USD","LU1934455277.USD","LU0661504455.SGD","IE0009355771.USD","LU0795875086.SGD","LU2471134952.CNY","GB00BDT5M118.USD","LU2896262040.SGD","LU2487616109.SGD","LU1674673428.USD","SG9999017495.SGD","LU1551013425.SGD","LU1023059063.AUD","IE000BZT7R73.USD","LU0210536198.USD","LU0456855351.SGD","LU2750360997.AUD","LU1037948897.HKD","BK4581","LU1670710661.SGD","LU1674673691.USD","LU1983299246.USD","LU0096364046.USD","LU1929549753.HKD","LU0965508806.USD","LU0098860793.USD","LU0985320562.USD","LU2471134796.USD","IE0002270589.USD","BK4585","IE00B7SZLL34.SGD","LU0786609619.USD","SGXZ80539844.SGD","LU0306806265.USD","IE00BK4W5M84.HKD","LU1506573853.SGD","LU1232071149.USD","IE0004445015.USD","LU1244550577.SGD","LU1064131342.USD","BK4588","LU1145028129.USD","SG9999001440.SGD","LU0109394709.USD","SG9999015986.USD","LU1196500208.SGD","LU2750360641.GBP","LU0553294199.USD","GDOC","BK4568","LU1032955483.USD","LU1935042991.SGD","LU0385154629.USD","LU1670628061.USD","SGXZ81514606.USD","LU0471298694.HKD","LU1267930573.SGD","LU1829250122.USD","LU0069063385.USD","LU0787776722.HKD","LU2125154778.USD","LU0964807845.USD","LU1043141396.HKD","LU2468319806.SGD","SG9999015358.SGD","GILD","IE00BVYPNV92.GBP","LU2357305700.SGD","LU1291159041.SGD","LU1057294990.SGD","LU2089984988.USD","LU2430703251.USD","IE00BFSS8Q28.SGD","IE00BSNM7G36.USD","LU1043141123.HKD","LU2360032135.SGD","GSK","LU0354030438.USD","LU0238689110.USD","LU0689472784.USD","BK4599","LU0943347566.SGD","IE00BJJMRY28.SGD","NVOX","LU2112291526.USD","LU0289961442.SGD","IE00B42XCP33.USD","LU0306807586.USD","LU0122379950.USD","LU2552382215.SGD","LU0648001328.SGD","LU0225284248.USD","LU1699723380.USD","LU1280957306.USD","OZEM","LU0511384066.AUD","LU1066051498.USD","LU2324357040.USD","LU2168564149.EUR","LU1868836757.USD","IE00BKVL7J92.USD","TBXU","LU1548497426.USD","LU0912757837.SGD","LU0965509010.AUD","LU1732800096.USD","SG9999013999.USD","LU2242652126.USD","ILDR","LU0985481810.HKD","LU0225283273.USD","LU1629891620.HKD","IE00BKDWB100.SGD","LU0345769128.USD","ABBV","LU0265550359.USD","LU2430703095.HKD","SG9999014906.USD","LU0321505868.SGD","IHE","LU0053666078.USD","IE00B3T34201.USD","IE000F7OJYX1.SGD","LU0210528500.USD","LU0211328371.USD","LU0861579265.USD","LU1989771016.USD","LU2361045086.USD","TRUH","LU2237443895.HKD","AGNG","SG9999003800.SGD","IE00B7KXQ091.USD","LU0057025933.USD","LU1267930490.SGD","LU0353189680.USD","LU2087621335.USD","LU0079474960.USD","SG9999011175.SGD","LU0994945656.USD","LU1228905037.USD","LU2125909247.SGD","SGXZ31699556.SGD","LU0726765562.USD","IE00BN8TJ469.HKD","LU1162221912.USD","LU1868836591.USD","IE00BJJMRX11.SGD","LU0859254822.USD","LU1066051225.USD","IXJ","IE00B19Z9P08.USD","LU2264538146.SGD","IE00BGHQF631.EUR","PJP","LU1069344957.HKD","LU1894683348.USD","NVOH","LU0070302665.USD","BK4504","LU0237698245.USD","LU0545562505.USD","PFE","LU2491050154.USD","IE0005OL40V9.USD","LU1923622614.USD","LU0426417589.USD","AZN","LU1804176565.USD","IE00B894F039.SGD","LU1941712348.USD","LU1037948541.HKD","ELIS","LU0823434740.USD","IE000M9KFDE8.USD","LU0689626769.HKD","LU2168563687.JPY","RXL","SG9999018865.SGD","LU1116320737.USD","LU1261432733.SGD","BK4550","BK4583","LU1868836914.USD","BK7501","LU0320765489.SGD","LLY","LU2505996681.GBP","BIIB","LU2237443382.USD","AMGN","LU1221951129.SGD","LU0097036916.USD","MRK","LU2168564065.EUR","LU1894683264.USD","BK4532","LU0130517989.USD","LU1941712264.USD","LU2433249047.HKD","LU2023250843.SGD","LU0267386448.USD","MEDI","BBH","BK4566","LU1035773651.USD","IE00B3PB1722.GBP","IE00B19Z9Z06.USD","IYH","SG9999014880.SGD","LU1069347547.HKD","LU0965509101.SGD","LU2361044949.HKD","SG9999015945.SGD","LU1718418525.SGD","LU0203347892.USD","LU2023250504.SGD","LU1868837300.USD","LU1035775433.USD","LU0738911758.USD","CURE","LU2265009873.SGD","SG9999015952.SGD","LU0203202063.USD","LU2462157665.USD","LU1623119135.USD","LU1934455194.USD","BIB","LU2125154935.USD","LU2063271972.USD","LU0640476718.USD","MEDX","LU0158827948.USD","SG9999001176.SGD","LU1732799900.SGD","LU2237438978.USD","SG9999014575.USD","LU2552382132.HKD","IE0001KFT4U8.USD","LU0198837287.USD","LU0980610538.SGD","SG9999018857.SGD","PBE","SGXZ57979304.SGD","IE00BJLML261.HKD","LU2213496289.HKD","LU0162691827.USD","SG9999014567.USD","LU0203201768.USD","LU2756315664.SGD","LU0466842654.USD","IBBQ","IE00BKPKM429.USD","LU1934455863.HKD","BK4559","LU0345770993.USD","LU2347655073.USD","LU2087625088.SGD","IE00BFXG1179.USD","LU2456880835.USD","LU1267930813.SGD","LU2168564495.EUR","LU1244550221.USD","LU2242646821.SGD","IE00BN29S564.USD","LU0708994859.HKD","LU2462591350.SGD","BK4516","IE00B2B36J28.USD","LU0310799852.SGD","IE0004445239.USD","IE0000B7K699.USD","LU1720051108.HKD","LU0158827781.USD","LU0942090050.USD","IE00BJT1NW94.SGD","LU1585245621.USD","LU2237443549.SGD","IE00BFSS7M15.SGD","LU0320765646.SGD","GSK.UK","TMED","IE00B775H168.HKD","LU1032466523.USD","LU1093756325.SGD","BK4139","LU2089283258.USD","IE00B1XK9C88.USD","IE000WAW04H5.SGD","IE00BK4W5L77.USD","LU1989772840.SGD","LU0289739699.SGD","LU1221951046.USD","LU0094547139.USD","LU0211327993.USD","04332","JNJ","IE0002141913.USD","LU0174119429.USD","LU0170899867.USD","IE000MB6IJN5.SGD","THNR","LU0820562030.AUD","LU1839511570.USD","LU2237443978.SGD","PPH","LU0234572021.USD","LU2471134879.HKD","FHLC","LU1430594728.SGD","LU2602419157.SGD","LU0395794307.EUR","LU1571399168.USD","SG9999014559.SGD","LU2028103732.USD","LU0109391861.USD","LU0471298777.SGD","IE00BWXC8680.SGD","LU2403377893.USD","LU1670710588.SGD","JDOC","LU1778281490.HKD","BK7511","LU2023251221.USD","LU2596442595.SGD","LU0265550946.USD","LU1670711123.USD","AZNH","SGXZ51526630.SGD","LU1003077747.HKD","LU0354030511.USD","LU1323610961.USD","LU1989772923.USD","LU1061106388.HKD","LU2417539215.USD","BK4592","LU0426412945.USD","LU2237443622.USD","LU0949170772.SGD","LU2023250330.USD","LU2129689514.USD","LU2361044865.SGD","SG9999015341.SGD","SG9999014898.SGD","LU1366192091.USD","IE00BLSP4239.USD","LU0070217475.USD","LU2430703178.SGD","XLV","SG9999001176.USD","LU0225771236.USD","IBB","LU2471134523.USD","LU0058720904.USD","LU0672654240.SGD","LU0289739343.SGD","LU2746668461.USD","SGXZ99366536.SGD","IE00B19Z3581.USD","LU2111349929.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658535936","title":"GLP-1为王、专利悬崖逼近、新赛道抢跑 跨国药企2026上半年业绩背后的版图重组","url":"https://stock-news.laohu8.com/highlight/detail?id=2658535936","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658535936?lang=zh_cn&edition=fundamental","pubTime":"2026-08-10 20:00","pubTimestamp":1786363243,"startTime":"0","endTime":"0","summary":"近日，全球制药巨头相继交出上半年成绩单。礼来、诺和诺德、赛诺菲、阿斯利康、辉瑞、罗氏等头部企业业绩陆续揭晓。GLP-1赛道的王座之争已无悬念，而专利悬崖、集采冲击与管线焦虑，正迫使跨国药企加速寻找下一个增长引擎。GLP-1王座之争：礼来登顶8月5日，礼来公布2026年上半年业绩——总营收427.73亿美元，同比增长49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608103836820982.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608103836820982.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BME","PBPH","BBH","IYH","BBP","IHE","GLP","TRUH","BK4590","APXH","MEDI","GSKH","BK4144","PJP","FXH","RSPH","JDOC","PPH","FHLC","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657641919","title":"GLP-1为王、专利悬崖逼近、新赛道抢跑：跨国药企2026上半年业绩背后的版图重组","url":"https://stock-news.laohu8.com/highlight/detail?id=2657641919","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657641919?lang=zh_cn&edition=fundamental","pubTime":"2026-08-07 21:49","pubTimestamp":1786110543,"startTime":"0","endTime":"0","summary":"近日，全球制药巨头相继交出上半年成绩单。礼来、诺和诺德、赛诺菲、阿斯利康、辉瑞、罗氏等头部企业业绩陆续揭晓。GLP-1赛道的王座之争已无悬念，而专利悬崖、集采冲击与管线焦虑，正迫使跨国药企加速寻找下一个增长引擎。GLP-1王座之争：礼来登顶8月5日，礼来公布2026年上半年业绩——总营收427.73亿美元，同比增长49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608073835488463.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608073835488463.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["TMED","PPH","BK4144","JDOC","FHLC","IHE","GSKH","PJP","BK4590","BME","BBP","IYH","MEDI","GLP","BBH","FXH","TRUH","PBPH","RSPH","APXH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656080539","title":"阿斯利康拟与百时美施贵宝4000亿美元重组传闻背后：专利悬崖、产品短板倒逼，AZ端反对声大","url":"https://stock-news.laohu8.com/highlight/detail?id=2656080539","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656080539?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 17:26","pubTimestamp":1785835565,"startTime":"0","endTime":"0","summary":"蓝鲸新闻记者联系了阿斯利康方面，对方拒绝对此置评。此外，BMS有神经管线与Eliquis后续心血管资产，可补足AZ在相关领域的短板。据BMO资本在研报中指出，两家公司都没有足够的财务实力直接收购对方，预计阿斯利康能掏出约370亿美元，而百时美施贵宝约为320亿美元，远低于搞定一桩价值4000亿美元合并所需的资金。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1785835141389493693","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["AZN","BMY","BME","LU0267386448.USD","BK4588","TMED","LU2237443382.USD","LU1868837300.USD","LU2237443895.HKD","AZNH","LU0882574055.USD","PPH","IHE","LU1670710588.SGD","LU2089984988.USD","LU1093756168.USD","LU0985481810.HKD","GSKH","LU2242646821.SGD","FTXH","PBPH","TRUH","LU1585245621.USD","IYH","AZ","BBH","RSPH","FXH","LU0868494617.USD","LU1032466523.USD","LU0321505439.SGD","LU1868836591.USD","LU2596442595.SGD","FHLC","LU1868836914.USD","PJP","LU0432979614.USD","APXH","IE00BJJMRZ35.SGD","BBP","LU2462157665.USD","MEDI","JDOC","IE00B2B36J28.USD","LU0321505868.SGD","LU1093756325.SGD","LU0225284248.USD","LU0128525929.USD","LU1670711123.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656493343","title":"据英国金融时报报道英国制药商阿斯利康一直在探索与美国竞争对手百时美施贵宝合并的交易合并后将打造全球最大的制药集团之一市值","url":"https://stock-news.laohu8.com/highlight/detail?id=2656493343","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656493343?lang=zh_cn&edition=fundamental","pubTime":"2026-08-03 03:22","pubTimestamp":1785698576,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B3T34201.USD","LU0889565916.HKD","AZNH","LU2236285917.USD","IHE","LU2237443978.SGD","AZN","LU0306806265.USD","LU2133065610.SGD","LU0289739699.SGD","LU0321505868.SGD","LU1267930573.SGD","LU2125154778.USD","BMY","LU2456880835.USD","LU1670711123.USD","LU1868837300.USD","IE00BJJMRZ35.SGD","BK4007","FTXH","GSKH","LU0225771236.USD","LU0868494617.USD","LU0321505439.SGD","LU2125154935.USD","IE00B2B36J28.USD","LU1868836757.USD","LU1989771016.USD","LU1571399168.USD","BK4559","LU0456855351.SGD","LU2237443622.USD","BK4588","IE0009355771.USD","LU2237443549.SGD","LU0061475181.USD","LU1261432733.SGD","LU1868837136.USD","LU2360032135.SGD","LU2417539215.USD","LU1093756168.USD","BK4532","LU1323610961.USD","LU2089984988.USD","LU0708994859.HKD","LU0109394709.USD","LU1032466523.USD","LU0114720955.EUR","LU2237443895.HKD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655336136","title":"GSK上半年核心营业利润增长 管线优化同步推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2655336136","media":"经济参考网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655336136?lang=zh_cn&edition=fundamental","pubTime":"2026-07-31 21:00","pubTimestamp":1785502815,"startTime":"0","endTime":"0","summary":"7月28日，葛兰素史克（GSK）公布2026年第二季度及上半年业绩。财报显示，今年上半年，葛兰素史克实现总营收160.38亿英镑，同比增长5%（以固定汇率计价，下同）；受期内药物临床试验失败等因素影响，公司总营业利润为27.74亿英镑，同比减少31%。不过，公司核心营业利润（剔除非经常性项目后的“常态化”利润）为54.50亿英镑，同比增长8%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202607313828578150.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607313828578150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["GSK.UK","LU1829250122.USD","GSK","BK4007","BK4532","GSKH","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654888584","title":"美股异动 | 医药板块走强 葛兰素史克(GSK.US)绩后大涨超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654888584","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654888584?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 22:50","pubTimestamp":1785250222,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","GSK","BK4588","GSK.UK","LU1829250122.USD","BK4007","GSKH","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117275596","title":"美股异动｜医药股板块普涨，葛兰素史克涨近7%，安进涨超5%，艾伯维公司涨近4%，辉瑞、默沙东涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117275596","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117275596?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 22:29","pubTimestamp":1785248946,"startTime":"0","endTime":"0","summary":"7月28日，医药股板块普涨，葛兰素史克涨近7%，安进涨超5%，艾伯维公司涨近4%，辉瑞、默沙东涨超3%，强生涨近3%，礼来涨超2%。消息面上，葛兰素史克公布的二季度财报显示，调整后每股收益为50.5便士，显著高于市场预期的46.8便士，盈利表现超出预期。与此同时，葛兰素史克宣布计划到2029年全面实现每年19亿英镑的成本节约，这一目标进一步增强了投资者对公司未来盈利能力的信心。","market":"us","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LLY","GSK","GSKH","ELIL","MRK","AMGN","ELIS","LLYX","ABBV","LLYZ","JNJ","PFE","LLII"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1134607161","title":"美股开盘 | 三大指数涨跌不一，康宁跌超14%，葛兰素史克涨超4%，可口可乐涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1134607161","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134607161?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 21:31","pubTimestamp":1785245499,"startTime":"0","endTime":"0","summary":"7月28日，美股三大指数开盘涨跌不一，道指涨0.66%，纳指跌0.61%，标普500跌0.14%。康宁跌超14%，Q2营收利润双超预期，但Q3收入指引不够“惊喜”；葛兰素史克涨超4%，可口可乐涨超3%，波音、PayPal涨近1%。","market":"us","thumbnail":"https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ff6e3231d788a5a6d28cf7965385cc7f"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4170","HIBL","PTF","SDOW","DIA","SMAX","SPDN","PYPL","GLWG","LU1861215975.USD","SPXS","SPXL","DRAM",".SPX","DDM","SPXU","SPYQ","GSKH","MMAX","RAM","UDOW","BOEU","KO","UPRO","SSO",".DJI","DOG","IVV","LU2290526834.HKD","PYPY","PYPG","BA","BK4588","UUP","BOED","LU0963586101.USD","SPYM","UDN","GSK","SPYH","DXD","SPYU","VOO",".IXIC","LU0054578231.USD","LU1861220033.SGD","SPY","SDS","YSPY","GLW","LU2360107168.USD","BOEG","SH","DMAX","CNAV","SPUU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654001756","title":"葛兰素史克首席执行官：媒体电话会议发言称，我们认为公司现有营收与收益流规模充足，足以抵消艾滋病药物专利失效带来的损失。","url":"https://stock-news.laohu8.com/highlight/detail?id=2654001756","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654001756?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 20:03","pubTimestamp":1785240196,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1829250122.USD","BK4588","GSK","BK4585","GSK.UK","BK4007","BK4532","GSKH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654016400","title":"葛兰素史克首席执行官就剑桥投资表示，我们并未寻求英国政府支持。","url":"https://stock-news.laohu8.com/highlight/detail?id=2654016400","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654016400?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 19:52","pubTimestamp":1785239557,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4585","LU1829250122.USD","BK4532","GSKH","BK4007","GSK","GSK.UK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654009999","title":"葛兰素史克拟在英国剑桥生物医学园区建立新旗舰研发中心","url":"https://stock-news.laohu8.com/highlight/detail?id=2654009999","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654009999?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 19:26","pubTimestamp":1785238009,"startTime":"0","endTime":"0","summary":null,"market":"uk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GSK.UK","BK4532","BK4588","LU1829250122.USD","GSK","GSKH","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654695009","title":"葛兰素史克美股盘前涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654695009","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654695009?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 19:23","pubTimestamp":1785237809,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["GSKH","LU1829250122.USD","BK4588","GSK","BK4007","GSK.UK","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654300952","title":"葛兰素史克：未来三年内向英国投资4亿英镑","url":"https://stock-news.laohu8.com/highlight/detail?id=2654300952","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654300952?lang=zh_cn&edition=fundamental","pubTime":"2026-07-28 19:21","pubTimestamp":1785237674,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["GSK.UK","BK4532","BK4588","LU1829250122.USD","GSK","GSKH","BK4585","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":91,"code":"91000000","status":"200"}]}}